AI In-Brief

Thailand News in Brief

Thai PBS World

Thailand and the world, every day

AI can make mistakes. Please double-check.

US approves 1st vaccine for RSV after decades of attempts

13 Sept 11:43 Key points summarised by AI

The U.S. Food and Drug Administration (FDA) approved GSK's Arexvy, the first-ever vaccine for Respiratory Syncytial Virus (RSV), specifically for adults aged 60 and older, marking a significant medical breakthrough after decades of research failures.
RSV poses a substantial health threat to older adults, responsible for up to 177,000 hospitalizations and 14,000 deaths annually; the new vaccine demonstrated nearly 83% effectiveness in preventing RSV lung infections and a 94% reduction in severe cases.
The vaccine is anticipated for rollout this fall, pending a June decision from the Centers for Disease Control and Prevention (CDC) on whether to recommend it for all seniors or only those at high risk, with other RSV vaccines for different age groups also in development.

Yesterday 12:56 Key points summarised by AI

President Macron condemned widespread rioting and looting during nationwide protests, blaming far-left activists and criminals for the "unrestrained violence" and vowing accountability for those who "sought to bring down the Republic."
Over 2,400 arrests were made as protests against rising living costs and poor school conditions escalated, causing extensive damage to public buildings and businesses in cities like Paris, Limoges (where City Hall burned), Marseille, and Lyon.
The unrest, which organizers hoped would revive the "yellow vest" movement, saw political leaders trade blame, with Macron instructing prefects to protect public buildings and potentially ban future protests to prevent further disorder.